Clinical Trial Update: Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

This update notes that a Phase 1 trial evaluating neutron therapy for stage III non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Lung Cancer | Phase 1 | Status: WITHDRAWN